A5058462111- Pregnancy and Medication Impact
- Reproductive System and Pregnancy
- Psoriasis: Treatment and Pathogenesis
- Dermatology and Skin Diseases
- Eosinophilic Esophagitis
- Spondyloarthritis Studies and Treatments
- Maternal Mental Health During Pregnancy and Postpartum
- Dermatological diseases and infestations
- Urticaria and Related Conditions
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical studies and practices
Bispebjerg Hospital
2018-2024
University of Copenhagen
2022-2023
Copenhagen University Hospital
2018-2023
Frederiksberg Hospital
2020-2022
Remote monitoring was used to assess and manage skin diseases.To investigate what extent smartphone photographs along with a self-reported body region (BR) score can be evaluate psoriasis severity.Psoriasis severity assessed in the clinic using area index physician's global assessment. On same day, patients took photograph of representative lesion from 4 BR (head/neck, upper limbs, trunk, lower limbs) completed questionnaire about score. The were rated by 5 dermatologists. Intraclass...
The chronic systemic inflammation associated with psoriasis supposedly creates an undesirable milieu for a pregnancy, resulting in increased risk of adverse pregnancy outcomes (APOs).To investigate the association between and APOs as well how differs according to severity (mild moderate-to-severe).This nationwide register-based case-control study collected data from 1973 2017. Cases were (spontaneous abortion, ectopic [EP], intrauterine fetal death, stillbirth). Singleton live births...
Psoriasis is a disease that extends beyond the skin, with profound medical, social, and mental health implications. To our knowledge, no previous studies have specifically investigated medical socioeconomic characteristics of women versus without psoriasis.
Little is known about the therapeutic benefits of a value-based healthcare model compared to traditional activity-based incentive in psoriasis (PsO).
Patients with chronic inflammatory diseases (CIDs) may encounter challenges in their family planning journey. Here, we report on the access to and pregnancy (FPP) information concerns among patients Denmark CIDs. aged 18–50 years CIDs participated an online survey. were recruited through patient advocacy groups asked diagnosis, related FPP perceptions of information. Descriptive statistics applied. Of eligible respondents, 368 had rheumatological diagnoses (rheumatoid arthritis, psoriatic...
Background: Patients affected by chronic inflammatory diseases of the skin or joints (CIDs; including psoriasis [PSO], rheumatoid arthritis [RA], juvenile idiopathic [JIA], psoriatic [PsA], non-radiographic axial spondyloarthritis [nr-axSpA; reported in survey as ‘axSpA’], ankylosing spondylitis [AS]) may be challenged their attempts to have children. A multinational conducted Europe and US, 969 patients, revealed that most patients’ concerns regarding family planning pregnancy (FPP) were...
Women with certain inflammatory diseases have an increased risk of giving birth to infants who are small for gestational age (SGA) or preterm (PTB), maternal disease activity being the most important factor. However, previous studies investigating association between psoriasis and SGA scarce shown conflicting results.To investigate PTB, respectively, both overall stratified by severity.This was a nationwide register-based matched cohort study women 1 : 10 without on at delivery, body mass...